The Latest Breaking News from Nasdaq

Gold futures traded slightly higher on Tuesday. Investors, meanwhile, focused on some notable insider trades.

Cerence Inc (NASDAQ:CRNC) reported a second-quarter FY22 revenue decline of 12.5% year-on-year to $86.3 million, above the consensus of $84.6 million. Non-GAAP EPS of $0.33 missed the consensus of $0.34. Segments: Revenue from License fell 14.8% Y/Y to $46.3 million, Connected services decreased 30.3% Y/Y to $19.3 million, and Professional services rose 24.7% Y/Y…

Here's a roundup of top developments in the biotech space over the last 24 hours:

Turning Point Therapeutics, Inc. (NASDAQ: TPTX) received Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA) for its lead drug candidate Repotrectinib in Patients With One Prior ROS1 Tyrosine Kinase Inhibitor and no Prior Chemotherapy.

Reading Intl (NASDAQ:RDI) reported its Q1 earnings results on Tuesday, May 10, 2022 at 08:30 AM. Here's what investors need to know about the announcement. Earnings Reading Intl missed estimated earnings by 59.09%, reporting an EPS of $-0.7 versus an estimate of $-0.44.

Within the last quarter, BioNTech (NASDAQ:BNTX) has observed the following analyst ratings:

Over the past 3 months, 4 analysts have published their opinion on Heska (NASDAQ:HSKA) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Analysts have provided the following ratings for Upstart Hldgs (NASDAQ:UPST) within the last quarter:

Victory Capital Holdings (NASDAQ:VCTR) has observed the following analyst ratings within the last quarter: